Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane, , , , , , , , , and 2 other author(s). J Clin Oncol, 26 (11): 1810-1816 (2008)Is the Development of Orientation Selectivity Instructed by Activity?, , and . Journal of Neurobiology, (1999)Analysis of Linsker's Simulation of Hebbian Rules, and . Neural Computation, (1990)Opponent Inhibition: A Developmental Model of Layer 4 of the Neocortical Circuit, and . Neuron, (2002)Local Correlation-based Circuitry Can Account for Responses to Multi-Grating Stimuli in a Model of Cat V1, , and . Journal of Neurophysiology, (2001)Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100, , , , , , , , , and 6 other author(s). J.Clin.Oncol., 26 (28): 4672-4678 (2008)Experimental and Theoretical Studies of the Organization of Afferents to Single Orientation Columns in Visual Cortex, , , and . Cold Spring Harbor Symposia on Quantitative Biology, LV, page 515--527. Cold Spring Harbor Laboratory Press, (1990)Synaptic Economics: Competition and Cooperation in Synaptic Plasticity. Neuron, 17 (3): 371--374 (September 1996)Correlation-based Development of Ocularly Matched Orientation and Ocular Dominance Maps: Determination of Required Input Activities, and . Journal of Neuroscience, 18 (23): 9870--9895 (1998)Effect of treatment with sunitinib malate, a multitargeted tyrosine kinase inhibitor, on circulating plasma levels of VEGF, soluble VEGF receptors 2 and 3, and soluble KIT in patients with metastatic breast cancer, , , , , , , , , and . J Clin Oncol (Meeting Abstracts), 24 (18_suppl): 578 (2006)